GlaxoSmithKline yesterday stepped up its expansion into emerging markets, striking an alliance to sell more than 100 drugs of Dr Reddy's, the Indian generic pharmaceuticals maker, in Africa, the Middle East, the Asia Pacific and Latin America.
葛蘭素史克(GSK)昨日加快其進軍新興市場的步伐,該公司與印度非專利藥品制造商Dr Reddy's結盟,將在非洲、中東、亞太及拉美地區銷售后者生產的100多種藥品。
您已閱讀10%(325字),剩余90%(3017字)包含更多重要信息,訂閱以繼續探索完整內容,并享受更多專屬服務。